Suppr超能文献

阿拉伯胶树(Forsk.)海恩亚种拉迪纳多糖对链脲佐菌素-烟酰胺诱导的糖尿病大鼠的抗糖尿病活性。

Antidiabetic activity of Acacia tortilis (Forsk.) Hayne ssp. raddiana polysaccharide on streptozotocin-nicotinamide induced diabetic rats.

作者信息

Kumar Bhateja Pradeep, Singh Randhir

机构信息

Department of Pharmacology, Bhojia Dental College and Hospitals, Bhud, Baddi, Himachal Pradesh 173205, India.

Department of Pharmacology, M. M. University, Mullana, Ambala, Haryana 133207, India.

出版信息

Biomed Res Int. 2014;2014:572013. doi: 10.1155/2014/572013. Epub 2014 Jul 9.

Abstract

The present study was designed to investigate the antidiabetic activity of aqueous extract of Acacia tortilis polysaccharide (AEATP) from gum exudates and its role in comorbidities associated with diabetes in STZ-nicotinamide induced diabetic rats. Male albino Wistar rats were divided into control, diabetic control, glimepiride treated (10 mg/kg), and diabetic rats treated with 250, 500, and 1000 mg/kg dose of AEATP groups and fasting blood glucose, glycated hemoglobin, total cholesterol, triglyceride, LDL, VLDL, HDL, SGOT, and SGPT levels were measured. STZ significantly increased fasting blood glucose level, glycated hemoglobin, total cholesterol, triglyceride, LDL, VLDL, SGOT, and SGPT levels, whereas HDL level was reduced as compared to control group. After 7 days of administration, 500 and 1000 mg/kg dose of AEATP showed significant reduction (P < 0.05) in fasting blood glucose level compared to diabetic control. AEATP has also reduced total cholesterol, triglyceride, LDL, VLDL, SGOT, and SGPT levels and improved HDL level as compared to diabetic control group. Our study is the first to report the normalization of fasting blood glucose level, lipid profile, and liver enzyme in AEATP treated diabetic rats. Thus, it can be concluded that AEATP may have potentials for the treatment of T2DM and its comorbidities.

摘要

本研究旨在探讨阿拉伯胶渗出物中阿拉伯胶多糖水提取物(AEATP)的抗糖尿病活性及其在链脲佐菌素-烟酰胺诱导的糖尿病大鼠中与糖尿病相关合并症中的作用。将雄性白化Wistar大鼠分为对照组、糖尿病对照组、格列美脲治疗组(10 mg/kg)以及分别用250、500和1000 mg/kg剂量AEATP治疗的糖尿病大鼠组,并测量空腹血糖、糖化血红蛋白、总胆固醇、甘油三酯、低密度脂蛋白、极低密度脂蛋白、高密度脂蛋白、谷草转氨酶和谷丙转氨酶水平。与对照组相比,链脲佐菌素显著提高了空腹血糖水平、糖化血红蛋白、总胆固醇、甘油三酯、低密度脂蛋白、极低密度脂蛋白、谷草转氨酶和谷丙转氨酶水平,而高密度脂蛋白水平降低。给药7天后,与糖尿病对照组相比,500和1000 mg/kg剂量的AEATP使空腹血糖水平显著降低(P < 0.05)。与糖尿病对照组相比,AEATP还降低了总胆固醇、甘油三酯、低密度脂蛋白、极低密度脂蛋白、谷草转氨酶和谷丙转氨酶水平,并提高了高密度脂蛋白水平。我们的研究首次报道了AEATP治疗的糖尿病大鼠空腹血糖水平、血脂谱和肝酶的正常化。因此,可以得出结论,AEATP可能具有治疗2型糖尿病及其合并症的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e4b/4119902/becf90a2f240/BMRI2014-572013.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验